Nitric oxide – activated
macrophages produce large amounts of nitric oxide (NO), which induces both cytostasis and cytotoxicity to tumor cells both
in vitro and
in vivo. Nitric oxide-induced cytostasis targets
ribonucleotide reductase by rapid and reversible inhibition. However, other studies show there could be other targets that are responsible for producing long-lasting cytostasis in cells.
Lipopolysaccharide (LPS) and lipid A-associated protein – studies have demonstrated that LPS and LAP are potent macrophage activators that have been shown to stimulate tumoricidal (cytostatic) activity
in vitro. LAP and LPS were shown to stimulate C3H/HeJ macrophages to kill target tumor cells. It was concluded that LAP can deliver at least one of the triggering signals necessary for inducing macrophage activity that leads to cytostasis.
Polyunsaturated fatty acid – N-3 and n-6 polyunsaturated fatty acids were found to have a distinct effect on cell growth in certain human
urothelial cells. Cystostatic concentrations of n-3 and n-6 PUFA did not induce
apoptosis, but did cause permanent cellular growth arrest by effecting the cell cycle. Study shows that metabolites of the
lipoxygenase pathway are involved with the antiproliferation induce by PUFA. However, PUFA cytostatic activity is not tumor-specific. ==Medical uses==